POST vs REGN · P/E 15, rev $8.16B vs P/E 14, rev $14.34B
Post Holdings Inc (POST) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Post Holdings Inc (POST) is a packaged foods company listed on NYSE.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported POST revenue for 2025-09-30 was $8.16B. Net income was $335.8M. Revenue was up 3.0% from 2024-09-30 to 2025-09-30. POST currently screens at market cap $4.03B and trailing P/E 14.9.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
POST currently screens at market cap $4.03B and trailing P/E 14.9. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the POST and REGN stock pages for the full models.
Not investment advice.